PRISM Blog

5-MeO-DMT: A primer on a potent psychedelic

Image credit: Michael Garfield and Alex Grey artworks digitally combined By Melissa Warner and Jasmine Blom 5-MeO-DMT is a unique and compelling member of the modern psychedelic pharmacopoeia. Spectacular and

Read More »

Psychedelic Support and Harm Reduction

Exploring the PRISM and DanceWize partnership By Stephanie Tzanetis Psychedelic assisted-psychotherapy (PAP), as the name indicates, is a therapy session aided by psychedelic compounds. By comparison, psychedelic support, also known

Read More »

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.

PRISM

We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.

Newsletter

Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt
0

Start typing and press Enter to search